Adityo Prakash and Tom Cellucci

Adityo Prakash is the Chairman and CEO of Verseon International Corp. He started Verseon to change the way the world finds new medicines. His passion is building fundamental science-based solutions to major business problems that impact society. Prakash has led the development of Verseon’s drug discovery platform, novel drug pipeline, and overall business strategy. Under his leadership, Verseon has developed a variety of novel technologies to overcome the pitfalls of drug discovery and development. These advances include Deep Quantum Modeling™ (DQM) and VersAI™. DQM not only facilitates the design of drug structures inaccessible to the rest of the pharma industry but also models the interactions between these novel drug-like structures and target proteins with unprecedented accuracy. VersAI™ excels in making predictions based on the small, sparse datasets typical of the life sciences, demonstrating up to 35% greater accuracy than Google AutoML in peer-reviewed literature. These advances have helped Verseon to create a fast-growing pipeline of drug candidates whose uniquely desirable therapeutic profiles are poised to change the standard of care for heart attacks, strokes, diabetic end organ damage, cancers, and more. Previously, Prakash was the CEO and founder of Pulsent Corporation, where he was the primary inventor of technology at the heart of all video streaming today. With a track record of delivering industry firsts, he is an inventor on 40 patent families. Prakash received his BS in physics and mathematics from Caltech. || H.E. The Hon, Sir Dr. Thomas A. Cellucci, PhD, MBA is a serial entrepreneur, currently managing several high-tech firms. He was appointed the US Department of Homeland Security’s Director of the Research & Development Partnerships (RDP) Group managing over $12B in assets and over 1700 team members. He was also the first Chief Commercialization Officer in the US Federal Executive Branch and continues to assist the President of the United States and Chairman of the Joint Chiefs. In 1999, he founded Cellucci Associates, Inc. with headquarters at Harvard Square in Cambridge, MA. Cellucci writes about the intersection of emerging technology, commercialization, and implementation to protect the homeland. Cellucci earned a PhD in Physical Chemistry from the University of Pennsylvania (1984), an MBA from Rutgers University (1991), and a BS in Chemistry with Honors from Fordham University (1980). He holds two endowed Chairs at prestigious universities in Kazakhstan and has taught at Harvard Business School, Princeton University, and the University of Pennsylvania.